Contact this trialFirst, we need to learn more about you.
Behavioural Intervention
Intermittent Fasting for Weight Loss in Crohn's Disease
Recruiting1 award5 criteria
Calgary, Alberta
This trial will test if a 12-week IF intervention can help people with overweight or obesity and CD in clinical remission with elevated biomarkers of inflammation lose weight, decrease inflammation, and increase microbial functional diversity compared to standard medical management.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service